Skip to main content
African Journal of Urology

Table 1 Baseline characteristics

From: Safety and efficacy of prostatic artery embolization in patients with hematuria due to benign prostate hyperplasia

Variable

Descriptive (mean ± SD)

Age, years

72.6 ± 10.5

MRI prostate volume, mL

68.16 ± 8.39

HB, g/L

116.89 ± 4.61

IPSS

25.33 ± 3.93

Qmax, mL/s

7.09 ± 1.75

PSA, ng/mL

6.95 ± 1.40

Residual hematuria, mL

2.95 ± 0.85

QoL score

4.43 ± 0.25

IIEFS

9.34 ± 1.41

  1. MRI, magnetic resonance imaging; HB, hemoglobin; IPSS, International Prostatic Symptoms Score; Qmax, maximum urinary flow rate; PSA, prostate-specific antigen; QoL, quality of life; and IIEFS, International Index of Erectile Function Score
Back to article page